"We know that the unmet medical need of depression is increasingly urgent. With more than 300 million people living with depression worldwide – a third of whom are not helped by standard treatments – we cannot wait to take action. We are committed to bridging the gap between what people living with mental health illnesses need, and what the system can currently provide."

Florian Brand

Independent Director

Co-founder and Chief Executive Officer of ATAI Life Sciences

Florian is Co-founder and CEO of ATAI Life Sciences, a global biotech company builder. He has also previously served as CEO of Perception Neuroscience and as Managing Director of Springlane GmbH. He is a member of the board of directors of Perception Neuroscience, GABA Therapeutics, EntheogeniX Biosciences, DemeRX IB, Viridia Life Sciences, IntroSpect Digital Therapeutics, and Innoplexus.

"We know that the unmet medical need of depression is increasingly urgent. With more than 300 million people living with depression worldwide – a third of whom are not helped by standard treatments – we cannot wait to take action. We are committed to bridging the gap between what people living with mental health illnesses need, and what the system can currently provide."